Research map: Predicting Poor Efficacy of Cabozantinib in Advanced Renal Cell Carcinoma by Exploratory Metabolic Pathway Analysis and In Vitro Verification

Back to the article

Papers in this map

  1. Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma · Toni K. Choueiri · 2021 · 1801 citations · Cited by this paper
  2. Association of the Affordable Care Act With Receipt of Guideline‐Concordant Adjuvant Chemotherapy for Colon and Non‐Small Cell Lung Cancer · 2026 · Related
  3. Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma · Toni K. Choueiri · 2015 · 1248 citations · Cited by this paper
  4. Comparative Cardiovascular Safety and Exploratory Bleeding Outcomes of Ibrutinib, Acalabrutinib, and Zanubrutinib in Mantle Cell Lymphoma: A Propensity Score‐Matched Real‐World Analysis · 2026 · Related
  5. An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma · A. Ari Hakimi · 2016 · 876 citations · Cited by this paper
  6. The Impact of the G8 Score on Survival Outcomes in Patients With Head and Neck Cancer Undergoing Concurrent Radiotherapy With Cetuximab due to Contraindications With Cisplatin · 2026 · Related
  7. Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update · Toni K. Choueiri · 2018 · 407 citations · Cited by this paper
  8. The Zuo Jin Wan Formula Reverses Cisplatin Resistance in Gastric Cancer by Inhibiting the Mitochondrial Translocation of Dynamin‐Related Protein 1 and Its Mediated Mitochondrial Fission and Mitophagy · 2026 · Related
  9. Mechanisms of drug resistance in HCC · Alexandra D. Ladd · 2023 · 361 citations · Cited by this paper
  10. Notch3/4 Knockdown Inhibits Colon Adenocarcinoma Progression by Suppressing Tumor Cell Activity and Orchestrating VEGFA ‐Dependent Tumor Immune Microenvironment · 2026 · Related
  11. Modulation of T cells by tryptophan metabolites in the kynurenine pathway · Trevor W. Stone · 2023 · 220 citations · Cited by this paper
  12. Overcoming Radiation Resistance: Ferroptosis Induction to Sensitize Solid Tumors to Radiation Therapy · 2026 · Related
  13. Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma · Toni K. Choueiri · 2024 · 181 citations · Cited by this paper
  14. Inhibition of the Metalloproteinase ADAMTS5 Suppresses Colorectal Cancer Metastasis via the PEDF /Wnt/β‐Catenin Pathway · 2026 · Related
  15. Protein and Amino Acid Metabolism in Cancer Cachexia: Investigative Techniques and Therapeutic Interventions · Peter W. T. Pisters · 1993 · 87 citations · Cited by this paper
  16. Machine Learning for Prediction of High‐Risk Infections in Patients With Cancer · 2026 · Related
  17. Identification of biomarkers to diagnose diseases and find adverse drug reactions by metabolomics · Daisuke Saigusa · 2020 · 79 citations · Cited by this paper
  18. Watch and Wait Strategy for Locally Advanced Rectal Cancer: Update From Results of Recent Clinical Trials · 2026 · Related
  19. Renal Cell Cancer – Insights in Drug Resistance Mechanisms · HALIMA AWEYS · 2023 · 70 citations · Cited by this paper
  20. The Influence of Resource Constraints on Risk‐Related Conversations With Specialists Among a Community‐Based Sample of Women at High Risk for Breast Cancer · 2026 · Related
  21. The Emerging Roles of Exosomes in the Chemoresistance of Hepatocellular Carcinoma · Jie Zhang · 2020 · 49 citations · Cited by this paper
  22. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma · Tomonori Sato · 2019 · 39 citations · Cited by this paper
  23. Histidine-Rich Glycoprotein Can Prevent Development of Mouse Experimental Glioblastoma · Maria Kärrlander · 2009 · 36 citations · Cited by this paper
  24. Accurate quantification of urinary metabolites for predictive models manifest clinicopathology of renal cell carcinoma · Tomonori Sato · 2020 · 28 citations · Cited by this paper
  25. Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis · Shobana Anpalakhan · 2023 · 28 citations · Cited by this paper
  26. Current evidence for second-line treatment in metastatic renal cell carcinoma after progression to immune-based combinations · Roberto Iacovelli · 2022 · 26 citations · Cited by this paper
  27. Comparison of Kit-Based Metabolomics with Other Methodologies in a Large Cohort, towards Establishing Reference Values · Daisuke Saigusa · 2021 · 22 citations · Cited by this paper
  28. Predictive model for recurrence of renal cell carcinoma by comparing pre‐ and postoperative urinary metabolite concentrations · Kento Morozumi · 2021 · 19 citations · Cited by this paper
  29. Reactive oxygen species–dependent upregulation of death receptor, tumor necrosis factor receptor 1, is responsible for theophylline-mediated cytotoxicity in MDA-MB-231 breast cancer cells · Poulami Tapadar · 2022 · 5 citations · Cited by this paper
  30. Elucidation and Regulation of Tyrosine Kinase Inhibitor Resistance in Renal Cell Carcinoma Cells from the Perspective of Glutamine Metabolism · Kento Morozumi · 2024 · 5 citations · Cited by this paper
  31. Metabolomic landscape of renal cell carcinoma in von Hippel-Lindau syndrome in a Chinese cohort · Zedan Zhang · 2024 · 5 citations · Cited by this paper
  32. Sequential Plasma Metabolome and Proteome Analyses to Develop a Novel Monitoring Strategy for Patients with Epithelial Ovarian Cancer: A Pilot Study · Eiji Hishinuma · 2025 · 4 citations · Cited by this paper
  33. Glutaminase inhibition confers antitumor effects in vitro and in vivo on tyrosine kinase inhibitors-resistant renal cell carcinoma cells by affecting vascular endothelial growth factor signaling · Kento Morozumi · 2025 · 2 citations · Cited by this paper
  34. Untitled · Cited by this paper

Source: OpenAlex (CC0)